Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference
2023-07-22 18:17
Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation
2023-07-21 23:44
Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA
2023-07-21 18:00
Saphnelo now available in Malaysia as an add-on treatment for adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE)
2023-07-21 10:00
Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed with LNK01004 in Phase Ib Clinical Study
2023-07-21 08:00
ADVANCEMENTS IN TREATMENT, DIAGNOSIS AND RISK REDUCTION STRATEGIES HIGHLIGHTED AT ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE
2023-07-20 21:01
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs
2023-07-20 19:15
PolyU awarded RGC Strategic Topics Grant to address societal needs in mental healthcare
2023-07-20 19:07
SayHeart: The AI Powerhouse Decoding Health Complexity
2023-07-20 19:03
2023 Brain Health and Disability Webinar: Leave No One Behind
2023-07-20 14:00
Gannex Announces the Completion of Patient Enrollment for Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis
2023-07-20 08:10
Harrison.ai Welcomes Robyn Denholm As Board Director
2023-07-20 05:00
SIMPLE FINGER PRICK TEST EXEMPLIFIES ADVANCES IN ALZHEIMER'S DISEASE BLOOD TESTS
2023-07-19 20:00
Significantly Reduce Manufacturing Cost and Increased Local Production: SCG Cell Therapy Opens State-of-the-art Cell Therapy Manufacturing Facility and R&D Centre in Singapore
2023-07-19 19:20
GHA Accreditation Helps Position Dr. Sulaiman Al-Habib Hospital in Al Khobar as a Trusted Destination for Medical Travel
2023-07-19 18:00
Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow
2023-07-19 16:14
The International Conference on Pharmaceutical Innovation and Development 2023 Kicked off in Yantai
2023-07-19 16:09
Philips Foundation partners with World Heart Federation to provide half a million children at risk of rheumatic heart disease with access to life-saving early detection
2023-07-19 15:30
BioWorld by Clarivate Recognized for Excellence in Publishing
2023-07-19 15:00
Daewoong Pharmaceutical has obtained approval for SGLT2i + metformin combination drug Envlomet
2023-07-19 08:52
1
55
56
57
58
59
491